These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8313399)

  • 1. Safety of moclobemide in clinical use.
    Chen DT; Ruch R
    Clin Neuropharmacol; 1993; 16 Suppl 2():S63-8. PubMed ID: 8313399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide safety: monitoring a newly developed product in the 1990s.
    Hilton S; Jaber B; Ruch R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):76S-83S. PubMed ID: 7593735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of moclobemide taken in overdose for attempted suicide.
    Hetzel W
    Psychopharmacology (Berl); 1992; 106 Suppl():S127-9. PubMed ID: 1546127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal moclobemide overdose or death caused by serotonin syndrome?
    Hernandez AF; Montero MN; Pla A; Villanueva E
    J Forensic Sci; 1995 Jan; 40(1):128-30. PubMed ID: 7876795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide (Ro 11-1163) safety in depressed patients.
    Moll E; Hetzel W
    Acta Psychiatr Scand Suppl; 1990; 360():69-70. PubMed ID: 2248078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Poisoning with a reversible and selective monoaminooxidase inhibitor].
    Pall M; Bested KM; Eriksen ND
    Ugeskr Laeger; 1997 Aug; 159(32):4859-60. PubMed ID: 9273760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moclobemide overdose.
    Myrenfors PG; Eriksson T; Sandsted CS; Sjöberg G
    J Intern Med; 1993 Feb; 233(2):113-5. PubMed ID: 8433071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine.
    Power BM; Pinder M; Hackett LP; Ilett KF
    Anaesth Intensive Care; 1995 Aug; 23(4):499-502. PubMed ID: 7485947
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association.
    François B; Marquet P; Desachy A; Roustan J; Lachatre G; Gastinne H
    Intensive Care Med; 1997 Jan; 23(1):122-4. PubMed ID: 9037653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe adverse reaction to moclobemide.
    O'Kane GM; Gottlieb T
    Lancet; 1996 May; 347(9011):1329-30. PubMed ID: 8622519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction studies with moclobemide.
    Zimmer R; Gieschke R; Fischbach R; Gasic S
    Acta Psychiatr Scand Suppl; 1990; 360():84-6. PubMed ID: 2248085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
    Berlin I; Saïd S; Spreux-Varoquaux O; Launay JM; Olivares R; Millet V; Lecrubier Y; Puech AJ
    Clin Pharmacol Ther; 1995 Oct; 58(4):444-52. PubMed ID: 7586937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A; Mikkelsen H; Angst J
    J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW; Maguire KP; Davies BM
    Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.
    Da Prada M; Zürcher G; Wüthrich I; Haefely WE
    J Neural Transm Suppl; 1988; 26():31-56. PubMed ID: 3283290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.